Carolina D. Solis-Herrera

Endocrinology

7703 Floyd Curl Dr
San Antonio, TX 78229

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Real-world predictors of progression to type 2 diabetes among adults with prediabetes.

Real-world predictors of progression to type 2 diabetes among adults with prediabetes.

Journal: Diabetes, obesity & metabolism

Published: September 26, 2025

Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.

Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.

Journal: Journal of the American College of Cardiology

Published: September 17, 2025

Semaglutide as a potential tool in pre-lung transplant weight loss optimization.

Semaglutide as a potential tool in pre-lung transplant weight loss optimization.

Journal: JCEM case reports

Published: August 12, 2025

Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice.

Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice.

Journal: Aging cell

Published: June 11, 2025

Post Hoc Analyses of DKD Clinical Trials in Ethnic Minorities (Asian, Hispanic, Black) Narrative Review.

Post Hoc Analyses of DKD Clinical Trials in Ethnic Minorities (Asian, Hispanic, Black) Narrative Review.

Journal: Clinical therapeutics

Published: February 18, 2025

Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes.

Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes.

Journal: Diabetes

Published: May 14, 2024

The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease.

The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease.

Journal: Diabetes, obesity & metabolism

Published: April 05, 2024

Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.

Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.

Journal: Clinical diabetes : a publication of the American Diabetes Association

Published: January 17, 2024

Leptin Reduction as a Required Component for Weight Loss.

Leptin Reduction as a Required Component for Weight Loss.

Journal: Diabetes

Published: July 21, 2023

Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.

Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.

Journal: Diabetes

Published: June 09, 2023

Non-steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes.

Non-steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: May 31, 2023

Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.

Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 08, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026